ID

40344

Beschreibung

Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation; ODM derived from: https://clinicaltrials.gov/show/NCT02232880

Link

https://clinicaltrials.gov/show/NCT02232880

Stichworte

Versionen (1)
  1. 10.04.20 10.04.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

10. April 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hypertension NCT02232880

Englisch

Eligibility Hypertension NCT02232880

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
men and women 18 to 65 years of age with hypertension, treated with three or more anti-hypertensive drugs, one being a diuretic, and
Beschreibung

Age | Hypertensive disease | Antihypertensive Agents Quantity | Diuretics Quantity

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0020538
UMLS CUI [3,1]
C0003364
UMLS CUI [3,2]
C1265611
UMLS CUI [4,1]
C0012798
UMLS CUI [4,2]
C1265611
having a systolic blood pressure >150 mmhg in the clinic and daytime average >150 mmhg on ambulatory blood pressure monitoring
Beschreibung

Systolic Pressure Clinic | Systolic Pressure Daytime Average Ambulatory Blood Pressure Monitoring

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0871470
UMLS CUI [1,2]
C0442592
UMLS CUI [2,1]
C0871470
UMLS CUI [2,2]
C0332169
UMLS CUI [2,3]
C1510992
UMLS CUI [2,4]
C0242876
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
medical history of secondary cause of hypertension, severe obesity (bmi >35), severe psychiatric disorders, cancer in the last 5 years other than nonmelanoma skin cell cancers, herpes zoster or cytomegalovirus that resolved less than 2 months before
Beschreibung

Secondary hypertension | Obesity Severe | Body mass index | Mental Disorders, Severe | Malignant Neoplasms | Exception Skin carcinoma | Herpes zoster disease | Cytomegalovirus Resolved Recent

Datentyp

boolean

Alias
UMLS CUI [1]
C0155616
UMLS CUI [2,1]
C0028754
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C1305855
UMLS CUI [4]
C4046029
UMLS CUI [5]
C0006826
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0699893
UMLS CUI [7]
C0019360
UMLS CUI [8,1]
C0010825
UMLS CUI [8,2]
C1514893
UMLS CUI [8,3]
C0332185
inability to return for abatacept treatment and follow-up for 24 weeks.
Beschreibung

Abatacept therapy Continue Unable | Follow-up Continue Unable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C4302766
UMLS CUI [1,2]
C0549178
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C3274571
UMLS CUI [2,2]
C0549178
UMLS CUI [2,3]
C1299582
inability to understand or complete study-related assessments.
Beschreibung

Evaluation Comprehension Unable | Completion Evaluation Unable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1261322
UMLS CUI [1,2]
C0162340
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0205197
UMLS CUI [2,2]
C1261322
UMLS CUI [2,3]
C1299582
current abuse of drugs or alcohol.
Beschreibung

Substance Use Disorders

Datentyp

boolean

Alias
UMLS CUI [1]
C0038586
receipt of any live vaccines within 3 months of the anticipated first dose of study medication.
Beschreibung

Vaccines, Attenuated

Datentyp

boolean

Alias
UMLS CUI [1]
C0042211
evidence of active or latent bacterial or viral infections at the time of potential enrollment, including human immunodeficiency virus (hiv)
Beschreibung

Bacterial Infections | Latent bacterial disease | Virus Diseases | Latent virus infection | HIV Infection | HIV Infection Latent

Datentyp

boolean

Alias
UMLS CUI [1]
C0004623
UMLS CUI [2]
C0596823
UMLS CUI [3]
C0042769
UMLS CUI [4]
C0596824
UMLS CUI [5]
C0019693
UMLS CUI [6,1]
C0019693
UMLS CUI [6,2]
C0205275
risk for tuberculosis
Beschreibung

At risk Tuberculosis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1444641
UMLS CUI [1,2]
C0041296
abnormal laboratory values including positive hepatitis b surface antigen, hemoglobin < 8.5 g/dl, white blood cell count < 3000/mm3, platelets < 100,000/mm3, creatinine > 2.5 times the upper limit of normal (uln), alanine aminotransferase or aspartate aminotransferase > 2 times the uln.
Beschreibung

Laboratory test result abnormal | Hepatitis B surface antigen positive | Hemoglobin measurement | White Blood Cell Count procedure | Platelet Count measurement | Serum creatinine raised | Alanine aminotransferase increased | Aspartate aminotransferase increased

Datentyp

boolean

Alias
UMLS CUI [1]
C0438215
UMLS CUI [2]
C0149709
UMLS CUI [3]
C0518015
UMLS CUI [4]
C0023508
UMLS CUI [5]
C0032181
UMLS CUI [6]
C0700225
UMLS CUI [7]
C0151905
UMLS CUI [8]
C0151904
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hypertension NCT02232880

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age | Hypertensive disease | Antihypertensive Agents Quantity | Diuretics Quantity
Item
men and women 18 to 65 years of age with hypertension, treated with three or more anti-hypertensive drugs, one being a diuretic, and
boolean
C0001779 (UMLS CUI [1])
C0020538 (UMLS CUI [2])
C0003364 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0012798 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
Systolic Pressure Clinic | Systolic Pressure Daytime Average Ambulatory Blood Pressure Monitoring
Item
having a systolic blood pressure >150 mmhg in the clinic and daytime average >150 mmhg on ambulatory blood pressure monitoring
boolean
C0871470 (UMLS CUI [1,1])
C0442592 (UMLS CUI [1,2])
C0871470 (UMLS CUI [2,1])
C0332169 (UMLS CUI [2,2])
C1510992 (UMLS CUI [2,3])
C0242876 (UMLS CUI [2,4])
Item Group
C0680251 (UMLS CUI)
Secondary hypertension | Obesity Severe | Body mass index | Mental Disorders, Severe | Malignant Neoplasms | Exception Skin carcinoma | Herpes zoster disease | Cytomegalovirus Resolved Recent
Item
medical history of secondary cause of hypertension, severe obesity (bmi >35), severe psychiatric disorders, cancer in the last 5 years other than nonmelanoma skin cell cancers, herpes zoster or cytomegalovirus that resolved less than 2 months before
boolean
C0155616 (UMLS CUI [1])
C0028754 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C1305855 (UMLS CUI [3])
C4046029 (UMLS CUI [4])
C0006826 (UMLS CUI [5])
C1705847 (UMLS CUI [6,1])
C0699893 (UMLS CUI [6,2])
C0019360 (UMLS CUI [7])
C0010825 (UMLS CUI [8,1])
C1514893 (UMLS CUI [8,2])
C0332185 (UMLS CUI [8,3])
Abatacept therapy Continue Unable | Follow-up Continue Unable
Item
inability to return for abatacept treatment and follow-up for 24 weeks.
boolean
C4302766 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C3274571 (UMLS CUI [2,1])
C0549178 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Evaluation Comprehension Unable | Completion Evaluation Unable
Item
inability to understand or complete study-related assessments.
boolean
C1261322 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0205197 (UMLS CUI [2,1])
C1261322 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Substance Use Disorders
Item
current abuse of drugs or alcohol.
boolean
C0038586 (UMLS CUI [1])
Vaccines, Attenuated
Item
receipt of any live vaccines within 3 months of the anticipated first dose of study medication.
boolean
C0042211 (UMLS CUI [1])
Bacterial Infections | Latent bacterial disease | Virus Diseases | Latent virus infection | HIV Infection | HIV Infection Latent
Item
evidence of active or latent bacterial or viral infections at the time of potential enrollment, including human immunodeficiency virus (hiv)
boolean
C0004623 (UMLS CUI [1])
C0596823 (UMLS CUI [2])
C0042769 (UMLS CUI [3])
C0596824 (UMLS CUI [4])
C0019693 (UMLS CUI [5])
C0019693 (UMLS CUI [6,1])
C0205275 (UMLS CUI [6,2])
At risk Tuberculosis
Item
risk for tuberculosis
boolean
C1444641 (UMLS CUI [1,1])
C0041296 (UMLS CUI [1,2])
Laboratory test result abnormal | Hepatitis B surface antigen positive | Hemoglobin measurement | White Blood Cell Count procedure | Platelet Count measurement | Serum creatinine raised | Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
abnormal laboratory values including positive hepatitis b surface antigen, hemoglobin < 8.5 g/dl, white blood cell count < 3000/mm3, platelets < 100,000/mm3, creatinine > 2.5 times the upper limit of normal (uln), alanine aminotransferase or aspartate aminotransferase > 2 times the uln.
boolean
C0438215 (UMLS CUI [1])
C0149709 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0023508 (UMLS CUI [4])
C0032181 (UMLS CUI [5])
C0700225 (UMLS CUI [6])
C0151905 (UMLS CUI [7])
C0151904 (UMLS CUI [8])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video